menu
    • menu
    [{"orgOrder":0,"company":"Veritaz Healthcare","sponsor":"Aurobindo Pharma Limited","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Small molecule","year":"2022","type":"Acquisition","leadProduct":"Azithromycin","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Veritaz Healthcare","amount2":0.02,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0.02,"dosageForm":"","sponsorNew":"Veritaz Healthcare \/ Aurobindo Pharma","highestDevelopmentStatusID":"12","companyTruncated":"Veritaz Healthcare \/ Aurobindo Pharma"}]

    Find Clinical Drug Pipeline Developments & Deals by Veritaz Healthcare

    Menu

    Veritaz Healthcare

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Veritaz Healthcare

                            India arrow
                            Pharmtech & Ingredients
                            Not Confirmed

                            Veritaz Healthcare

                            India arrow
                            Pharmtech & Ingredients
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Azithromycin

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Approved

                            Sponsor : Aurobindo Pharma Limited

                            Deal Size : $22.5 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Aurobindo Pharma Buys Veritaz for Rs 171 Crore to Enter Domestic Formulation Business

                            Details : Currently, the company caters to anti-infective and pain-management therapeutic areas and has a pipeline of products to enter into the cardio/diabetic and ortho/gynaecology segments, including Veriaz.

                            Brand Name : Veriaz

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            March 28, 2022

                            Lead Product(s) : Azithromycin

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Approved

                            Sponsor : Aurobindo Pharma Limited

                            Deal Size : $22.5 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth